Skip to main navigation
Skip to search
Skip to main content
Boise State University Home
Home
Profiles
Research units
Equipment
Projects
Research output
Datasets
Prizes
Activities
Press/Media
Student theses
Search by expertise, name or affiliation
Doxorubicin Analogs Show Potent In Vitro Anti-Breast Cancer Activity
Cole Rice
, Phil Moon
, Ryan Carfi
,
Don Warner
,
Ken Cornell
Chemistry Department
Boise State University
Research output
:
Contribution to conference
›
Poster
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Doxorubicin Analogs Show Potent In Vitro Anti-Breast Cancer Activity'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Pharmacology, Toxicology and Pharmaceutical Science
Breast Cancer
100%
Doxorubicin
100%
Side Effect
28%
Malignant Neoplasm
14%
Breast Tumor
14%
Antiinfective Agent
14%
Cancer Mortality
14%
Antiproliferative Activity
14%
Heart Injury
14%
Biochemistry, Genetics and Molecular Biology
Doxorubicin
100%
Cancer Cell
16%
Lifespan
16%
Cancer Mortality
16%
Low Drug Dose
16%
Antiproliferative Activity
16%